OrisDX

📍 Chicago, United States👥 7 employees💰 Last funded Oct 2025
Biotechnology🌐 orisdx.com
Website LinkedIn
Founded in research from the University of Chicago, OrisDX has developed a novel non-invasive salivary diagnostic test utilizing biomarker-based molecular genomic techniques to diagnose oral cavity cancers earlier.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in OrisDX?
OrisDX has 1 investors on record on gritt.io.
When did OrisDX last raise funding?
The most recent investment in OrisDX recorded on gritt.io was in October 2025.
What industry is OrisDX in?
OrisDX operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is OrisDX based?
OrisDX is headquartered in Chicago, United States.